Incruse Ellipta (umeclidinium)

pCPA File Number: 20860
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Obstructive Pulmonary Disease
Sponsor/Manufacturer:
GlaxoSmithKline
CADTH Project Number:
SR0422-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: